Philips will stop selling new sleep apnea devices in the United States. The healthcare technology group announced this when publishing its quarterly and annual figures. Philips has reached a settlement with the American medical regulator FDA, for which the company recorded a charge of 363 million euros in the past quarter.
ttn-3
Philips stops sales of sleep apnea devices in the US and settles with American medical regulator
